Muscle health and bladder cancer prognosis study
Part of Cancer clinical trials.
This study looks at how muscle health (sarcopenia) relates to the outlook for people with non-muscle-invasive bladder cancer. Participants will have a CT scan and routine blood tests before their planned tumor-removal surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have non-muscle-invasive bladder cancer (cancer that hasn't spread into the bladder muscle).
- You must be scheduled for a tumor removal surgery called TURBT.
- You must be able to have a CT scan and not have serious kidney problems or allergies to CT contrast dye.
- You must not have 'low risk' bladder cancer. Your doctor will know if this applies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tumor and blood samples from people with muscle-invasive bladder cancer to find markers that help predict how the disease will progress. It aims to improve personalized treatment for those with this specific stage of bladder cancer.
This trial tests if adding a special CT scan before bladder removal helps find muscle-invasive bladder cancer earlier. It includes people with different stages of bladder cancer who are planning to have their bladder removed.
This study looks at how well a standard chemotherapy given before surgery works for muscle-invasive bladder cancer. It aims to see if higher responses lead to better outcomes.
This study follows people with muscle-invasive bladder cancer who choose to keep their bladder (instead of removing it) after receiving chemotherapy, immunotherapy, or an ADC drug. It aims to see how well this approach works and what side effects may occur.
This trial looks at how the immune environment around a muscle-invasive bladder tumor changes after you receive treatment before surgery (neoadjuvant therapy). The goal is to understand why some tumors respond better, which could help guide future treatments.
This trial tests whether people with muscle-invasive bladder cancer can safely avoid immediate surgery or radiation after a short course of chemotherapy. Instead, they would be closely monitored and only treated if the cancer comes back.
Hear when a new Bladder Cancer Cell Transitional trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.